Abstract:A20 was originally characterized as a TNF-inducible gene in human umbilical vein endothelial cells. As an NF-kappa B target gene, A20 is also induced in many other cell types by a wide range of stimuli. Expression of A20 has been shown to protect from TNF-induced apoptosis and also functions via a negative-feedback loop to block NF-kappa B activation induced by TNF and other stimuli. To date, there are no reports on whether A20 can protect OxLDL-induced apoptosis in macrophages. For the first time we report that A20 expression blocks OxLDL-mediated cell toxicity and apoptosis. OxLDL induced the expression of Fas and FasL, and the subsequent caspase-8 cleavage and treatment with a neutralizing ZB4 anti-Fas antibody blocked apoptosis induced by OxLDL. Expression of dominant negative FADD efficiently prevented OxLDL-induced apoptosis and caspase-8 activation. A20 expression significantly attenuated the increased expression of Fas and FasL, and Fas-mediated apoptosis. These findings suggest that A20-mediated protection from OxLDL may occur at the level of Fas/FADD-caspase-8 and be FasL dependent. Treatment of RAW264.7 cells with OxLDL induces a series of time-dependent events, including the release of cytochrome c, Smac and Omi from the mitochondria to the cytosol, activation of caspase-9,-6,-2, and -3, which are blocked by A20 expression. No cleaved form of Bid was detected, even treatment with OxLDL for 48 h. Expression of dominant negative FADD also efficiently prevented OxLDL-induced the above apoptotic events. The release of cyto c, Smac and Omi from mitochondria to cytosol, activated by OxLDL treatment, and the activation of caspase-9 may not be a downstream event of caspase-8-mediated Bid cleavage. Therefore, the protective effect of A20 on mitochondrial apoptotic pathway activated by OxLDL may be dependent on FADD. A20 expression reversed OxLDL-mediated G(0)/G(1) stage arrest by maintaining the expression of cyclin B1, cyclin D1, and cyclin E, and p21 and p73. Thus, A20 expression blocks OxLDL-mediated apoptosis in murine RAW264.7 macrophages through disrupting Fas/FasL-dependent activation of caspase-8 and the mitochondria pathway.

Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation

A20 Overexpression under Control of Mouse Osteocalcin Promoter in MC3T3-E1 Cells Inhibited Tumor Necrosis Factor-Alpha-induced Apoptosis.

Neuroprotective Effect of A20 on TNF-Induced Postischemic Apoptosis

Antiapoptotic Effect Both in Vivo and in Vitro of A20 Gene when Transfected into Rat Hippocampal Neurons

A20 intrinsically influences human effector T‐cell survival and function by regulating both NF‐κB and JNK signaling

Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling

AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor–Induced ASK1-JNK Activation

Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor- -Activated Kinase 1-Dependent Signaling

A20 controls expression of beta-cell regulatory genes and transcription factors

Targeting A20 Enhances TRAIL-induced Apoptosis in Hepatocellular Carcinoma Cells

A20 Inhibits Oxidized Low‐density Lipoprotein‐induced Apoptosis Through Negative Fas/Fas Ligand‐dependent Activation of Caspase‐8 and Mitochondrial Pathways in Murine RAW264.7 Macrophages

Localization of A20 to A Lysosome-Associated Compartment and Its Role in Nf Kappa B Signaling

Inhibition of A20 Expression in Tumor Microenvironment Exerts Anti-Tumor Effect Through Inducing Myeloid-Derived Suppressor Cells Apoptosis

Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death

Znf216 is an A20-Like and I Kappa B Kinase Gamma-Interacting Inhibitor of Nf Kappa B Activation

A20 is dynamically regulated in the heart and inhibits the hypertrophic response

Inhibition of NLRP3 Inflammasome Activation by A20 Through Modulation of NEK7

A20 Inhibits Human Salivary Adenoid Cystic Carcinoma Cells Invasion Via Blocking Nuclear Factor-Kappa B Activation

A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell|[ndash]|mediated suppression

Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity

A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1